Participated in Psylink's €501K pre-seed round alongside Coinvest Capital and BSV Ventures for the psilocybin/mental-health biotech.
Psylink is a biotechnology company advancing an innovative platform for small-molecule drug development, focusing on biosynthesis of psychedelics and other therapeutic compounds
Psylink is a biotechnology company advancing an innovative platform for small-molecule drug development, focusing on biosynthesis of psychedelics and other therapeutic compounds.